Home
HelpTest Code LAGGN Granulocyte Antibody Screen, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Additional Information: Only a specimen collected before a transfusion reaction is acceptable.
Useful For
Work-up of individuals with autoimmune neutropenia
Work-up of individuals having febrile nonhemolytic transfusion reactions
Work-up for alloimmune neonatal neutropenia
This test is not useful for the diagnosis of neutropenia due to marrow suppression by drugs or tumors.
Method Name
Flow Cytometry/Agglutination
Reporting Name
Granulocyte Ab Screen, SSpecimen Type
Serum RedSpecimen Minimum Volume
0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum Red | Refrigerated (preferred) | 30 days |
| Frozen | 365 days | |
| Ambient | 7 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | OK |
| Gross icterus | OK |
Clinical Information
Granulocyte antibodies are induced by pregnancy, prior transfusion, or transplants. These antibodies can cause neutropenia in various autoimmune disorders. Febrile nonhemolytic transfusion reactions and alloimmune neonatal neutropenia may also be caused by granulocyte associated antibodies, including anti-human leukocyte antigen antibodies.
Reference Values
Not applicable
Interpretation
A positive result can be due to anti-granulocyte antibodies and anti-human leukocyte antigen antibodies.
This test cannot distinguish between allo- or autoantibodies, nor can it determine the specificity of the detected antibody. Results should be correlated to clinical history.
Cautions
Testing for patients who receive human monoclonal antibodies like daratumumab may cause false-positive results due to interfering substances. Hemolytic samples have the potential for causing false-positivity and will, therefore, be rejected.
Day(s) Performed
Tuesday, Thursday
Report Available
7 to 15 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86021 x2
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| LAGGN | Granulocyte Ab Screen, S | 105285-1 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| LAGG2 | GIFT/GAT Interpretation | 105288-5 |
| LAGG3 | GIFT Result | 105286-9 |
| LAGG4 | GAT Result | 105287-7 |